Controle da produção de aflatoxinas no amendoim em casca úmido com ortofenilfenato de sódio: III. Testes no armazém

The present experiment aimed to evaluate the effect of sodium ortho-phenylphenate (SOP) application to in-shell moist peanuts for the control of aflatoxin production. Previous studies showed the need to improve the SOP solution distribution on peanut pods to evaluate the product. Thus, in this experiment the place of the spray system was the bag filler pipe of the pre-cleaning machine in the warehouse. In the 1989 rainy season two lots of 120 bags of in-shell moist peanuts were sprayed with 0.5 and 1% SOP solutions and aflatoxin production was not controlled. In the dry season of 1989 and in the rainy season of 1990, in-shell moist peanuts were sprayed with 5% SOP solution. The coverage of pods with the solution was efficient, allowing a uniform distribution of SOP solution on the pods. The results showed that only the 5.0% concentration of SOP solution utilized controlled the external fungal growth when a naked eye observation was made, however did not control aflatoxin production when applied to in-shell moist peanuts, probably due to the internal presence of Aspergillus flavus and because the fungicide could not penetrate inside to reach the kernels.O presente trabalho teve por objetivo avaliar a eficiência da solução de ortofenilfenato de sódio (OFS), no controle da produção de aflatoxinas quando aplicada no amendoim em casca, úmido. Trabalhos anteriormente realizados, em condições de campo, indicaram a necessidade de otimizar a aplicação da solução, para se poder avaliar a real eficiência dessa substância. Assim, neste experimento, o sistema de pulverização foi adaptado na bica de saída da máquina de pré-limpeza, no armazém. Na safra das águas de 1989, dois lotes de 120 sacos de amendoim em casca úmido foram pulverizados com solução de OFS em concentrações de 0,5 e 1,0 % e verificou-se que não houve controle da produção de aflatoxinas em ambas as concentrações utilizadas. Nas safras da seca de 1989 e das águas de 1990 o amendoim em casca úmido foi pulverizado com solução de OFS na concentração de 5,0%. A cobertura das vagens com a solução foi eficiente, permitindo uma distribuição uniforme da solução de OFS sobre as vagens. Os resultados obtidos mostraram que nenhuma das concentrações utilizadas controlou a produção de aflatoxinas, quando aplicadas no amendoim em casca, embora, aparentemente, tenham controlado o crescimento fúngico da parte externa das vagens de amendoim. Provavelmente os fungos aflatoxigênicos já poderiam estar presentes dentro de vagens sadias e desse modo a casca do amendoim poderia ser uma barreira à penetração do fungicida dentro da vagem e atingir as amêndoas

Analysis of access to hypertensive and diabetic drugs in the Family Health Strategy, State of Pernambuco, Brazil

OBJECTIVE: To evaluate the access to drugs for hypertension and diabetes and the direct cost of buying them among users of the Family Health Strategy (FHS) in the state of Pernambuco, Brazil. METHODS: Population-based, cross-sectional study of a systematic random sample of 785 patients with hypertension and 823 patients with diabetes mellitus who were registered in 208 randomly selected FHS teams in 35 municipalities of the state of Pernambuco. The selected municipalities were classified into three levels with probability proportional to municipality size (LS, large-sized; MS, medium-sized; SS, small-sized). To verify differences between the cities, we used the χ2 test. RESULTS: Pharmacological treatment was used by 91.2% patients with hypertension whereas 85.6% patients with diabetes mellitus used oral antidiabetic drugs (OADs), and 15.4% used insulin. The FHS team itself provided antihypertensive medications to 69.0% patients with hypertension, OADs to 75.0% patients with diabetes mellitus, and insulin treatment to 65.4%. The 36.9% patients with hypertension and 29.8% with diabetes mellitus that had to buy all or part of their medications reported median monthly cost of R$18.30, R$ 14.00, and R$ 27.61 for antihypertensive drugs, OADs, and insulin, respectively

In vitro nematicidal activity of naphthoquinones against the root-lesion nematode Pratylenchus thornei

The root-lesion nematode Pratylenchus thornei is a widely distributed and important parasite of cereals and legumes. As migratory endoparasites, P. thornei are difficult to manage  because they enter and leave host roots and may remain quiescent inside roots or in soil when conditions are unfavourable for plant growth. The number of available nematicides to manage these nematodes is restricted, so new, effective and eco-friendly sustainable management strategies are needed. The effects of naphthoquinones (juglone, 1,4-naphtoquinone and plumbagin) produced by some plants species, including walnut (Juglandaceae), were assessed against P. thornei. An additional treatment of a mixture of juglone and 1,4-naphtoquinone (2:1, w/w), was included because these compounds are frequently found at these propotion in walnut extracts. Juveniles and adult nematodes were exposed to different concentrations of each naphthoquinone and nematode mortality was assessed. Juglone and 1,4-naphthoquinone (at 500 ppm) were more effective than plumbagin, and gave 100% mortality after 24 h of exposure. A synergistic effect was not detected when juglone and 1,4-naphthoquinone (2:1, w/w) were combined. Estimated lethal concentrations causing 50% P. thornei mortality (LC50s) (72 h exposure) were: 134.7 ppm for juglone, 161.2 ppm for 1,4-naphthoquinone, 207.6 ppm for juglone + 1,4-naphthoquinone (2:1, w/w), and 178.8 ppm for plumbagin. This study has demonstrated the nematicidal potential of these naphthoquinones against P. thornei, and has shown that walnut residues may be valuable sources for extraction of these compounds

Search for a W' boson decaying to a bottom quark and a top quark in pp collisions at sqrt(s) = 7 TeV

Results are presented from a search for a W' boson using a dataset corresponding to 5.0 inverse femtobarns of integrated luminosity collected during 2011 by the CMS experiment at the LHC in pp collisions at sqrt(s)=7 TeV. The W' boson is modeled as a heavy W boson, but different scenarios for the couplings to fermions are considered, involving both left-handed and right-handed chiral projections of the fermions, as well as an arbitrary mixture of the two. The search is performed in the decay channel W' to t b, leading to a final state signature with a single lepton (e, mu), missing transverse energy, and jets, at least one of which is tagged as a b-jet. A W' boson that couples to fermions with the same coupling constant as the W, but to the right-handed rather than left-handed chiral projections, is excluded for masses below 1.85 TeV at the 95% confidence level. For the first time using LHC data, constraints on the W' gauge coupling for a set of left- and right-handed coupling combinations have been placed. These results represent a significant improvement over previously published limits.Comment: Submitted to Physics Letters B. Replaced with version publishe

Search for the standard model Higgs boson decaying into two photons in pp collisions at sqrt(s)=7 TeV

A search for a Higgs boson decaying into two photons is described. The analysis is performed using a dataset recorded by the CMS experiment at the LHC from pp collisions at a centre-of-mass energy of 7 TeV, which corresponds to an integrated luminosity of 4.8 inverse femtobarns. Limits are set on the cross section of the standard model Higgs boson decaying to two photons. The expected exclusion limit at 95% confidence level is between 1.4 and 2.4 times the standard model cross section in the mass range between 110 and 150 GeV. The analysis of the data excludes, at 95% confidence level, the standard model Higgs boson decaying into two photons in the mass range 128 to 132 GeV. The largest excess of events above the expected standard model background is observed for a Higgs boson mass hypothesis of 124 GeV with a local significance of 3.1 sigma. The global significance of observing an excess with a local significance greater than 3.1 sigma anywhere in the search range 110-150 GeV is estimated to be 1.8 sigma. More data are required to ascertain the origin of this excess.Comment: Submitted to Physics Letters

Measurement of the Lambda(b) cross section and the anti-Lambda(b) to Lambda(b) ratio with Lambda(b) to J/Psi Lambda decays in pp collisions at sqrt(s) = 7 TeV

The Lambda(b) differential production cross section and the cross section ratio anti-Lambda(b)/Lambda(b) are measured as functions of transverse momentum pt(Lambda(b)) and rapidity abs(y(Lambda(b))) in pp collisions at sqrt(s) = 7 TeV using data collected by the CMS experiment at the LHC. The measurements are based on Lambda(b) decays reconstructed in the exclusive final state J/Psi Lambda, with the subsequent decays J/Psi to an opposite-sign muon pair and Lambda to proton pion, using a data sample corresponding to an integrated luminosity of 1.9 inverse femtobarns. The product of the cross section times the branching ratio for Lambda(b) to J/Psi Lambda versus pt(Lambda(b)) falls faster than that of b mesons. The measured value of the cross section times the branching ratio for pt(Lambda(b)) > 10 GeV and abs(y(Lambda(b))) < 2.0 is 1.06 +/- 0.06 +/- 0.12 nb, and the integrated cross section ratio for anti-Lambda(b)/Lambda(b) is 1.02 +/- 0.07 +/- 0.09, where the uncertainties are statistical and systematic, respectively.Comment: Submitted to Physics Letters

Emerging role of insulin with incretin therapies for management of type 2 diabetes

Type 2 diabetes mellitus (T2DM) is a progressive disease warranting intensification of treatment, as beta-cell function declines over time. Current treatment algorithms recommend metformin as the first-line agent, while advocating the addition of either basal-bolus or premixed insulin as the final level of intervention. Incretin therapy, including incretin mimetics or enhancers, are the latest group of drugs available for treatment of T2DM. These agents act through the incretin axis, are currently recommended as add-on agents either as second-or third-line treatment, without concurrent use of insulin. Given the novel role of incretin therapy in terms of reducing postprandial hyperglycemia, and favorable effects on weight with reduced incidence of hypoglycemia, we explore alternative options for incretin therapy in T2DM management. Furthermore, as some evidence alludes to incretins potentially increasing betacell mass and altering disease progression, we propose introducing these agents earlier in the treatment algorithm. In addition, we suggest the concurrent use of incretins with insulin, given the favorable effects especially in relation to weight gain